Live
FierceBiotechGilead turns down chance to build on Assembly's phase 1-stage HBV antiviralFierceBiotechNovartis pays Synnovation $2B upfront for breast cancer program as rivals circleEndpoints NewsNovartis to pay $2B upfront to take next-gen PI3Kα inhibitor from SynnovationThermo FisherEU Clears Thermo Fisher's Multibillion-Dollar Clario Acquistion - marketscreener.comEndpoints NewsIdorsia looks for another CEO — again; Former Jazz exec makes a comebackEndpoints NewsGenentech culls muscle-preserving drug in genetic diseases, raising questions about obesity trialWatersFoguth Wealth Management LLC. Purchases New Stake in Waters Corporation $WAT - MarketBeatThermo FisherConfluence Investment Management LLC Acquires 11,841 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeatIlluminaIllumina, Inc. $ILMN Shares Sold by CIBC Private Wealth Group LLC - MarketBeatThermo FisherArgent Capital Management LLC Increases Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeatAgilentAgilent’s USCAP 2026 Pathology Updates Deepen Oncology Diagnostics Narrative - simplywall.stAgilentAIA Group Ltd Invests $2.48 Million in Agilent Technologies, Inc. $A - MarketBeat
FierceBiotech Jan 22, 2026

Hoth strikes back against cancer drug skin toxicities, but share price stays frozen

Hoth strikes back against cancer drug skin toxicities, but share price stays frozen

Original
Body unavailable. Use the original source.

Directory

59 All